Plasma Amyloid-β Levels, Cerebral Small Vessel Disease, and Cognition: The Rotterdam Study

Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs

(2016) Stefanie Lerche et al.   Alzheimers Research & Therapy

Association of Cerebral Microbleeds With Cognitive Decline and Dementia

(2016) Saloua Akoudad et al.   JAMA Neurology

Plasma β-amyloid in Alzheimer’s disease and vascular disease

(2016) Shorena Janelidze et al.   Scientific Reports

Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study

(2015) Vincent Chouraki et al.   Alzheimers & Dementia

Cerebral Microbleeds, CSF p-Tau, and Cognitive Decline: Significance of Anatomic Distribution

(2015) G.C. Chiang et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

The potential for prevention of dementia across two decades: the prospective, population-based Rotterdam Study

(2015) Renée FAG de Bruijn et al.   BMC Medicine

The Rotterdam Scan Study: design update 2016 and main findings

(2015) M. Arfan Ikram et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Increased levels of plasma amyloid-beta are related to cortical thinning and cognitive decline in cognitively normal elderly subjects

(2015) Sandra Llado-Saz et al.   NEUROBIOLOGY OF AGING

Amyloid biomarkers in Alzheimer's disease

(2015) Kaj Blennow et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Patterns of cognitive function in aging: the Rotterdam Study

(2014) Yoo Young Hoogendam et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Self-reported memory complaints: Implications from a longitudinal cohort with autopsies

(2014) R. J. Kryscio et al.   NEUROLOGY

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

(2013) Joanna M Wardlaw et al.   LANCET NEUROLOGY

Vascular disease and dementias: Paradigm shifts to drive research in new directions

(2012) Mitchel A. Kling et al.   Alzheimers & Dementia

Methods of data collection and definitions of cardiac outcomes in the Rotterdam Study

(2012) Maarten J. G. Leening et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Midlife Blood Pressure, Plasma β-Amyloid, and the Risk for Alzheimer Disease

(2012) Nilay S. Shah et al.   HYPERTENSION

Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria

(2012) Dimitri Renard et al.   JOURNAL OF NEUROLOGY

Plasma ß-Amyloid Levels in Cerebral Amyloid Angiopathy-Associated Hemorrhagic Stroke

(2012) Mar Hernandez-Guillamon et al.   Neurodegenerative Diseases

Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI

(2011) Jon B. Toledo et al.   ACTA NEUROPATHOLOGICA

Cerebral amyloid angiopathy in the elderly

(2011) Anand Viswanathan et al.   ANNALS OF NEUROLOGY

Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges

(2010) Leonardo Pantoni   LANCET NEUROLOGY

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

(2010) Kaj Blennow et al.   Nature Reviews Neurology

Cerebrospinal fluid amyloid β40is decreased in cerebral amyloid angiopathy

(2009) Marcel M. Verbeek et al.   ANNALS OF NEUROLOGY

Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease

(2008) Alex E. Roher et al.   Alzheimers & Dementia

Independent Generation of Aβ42 and Aβ38 Peptide Species by γ-Secretase

(2008) Eva Czirr et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Brain tissue volumes in relation to cognitive function and risk of dementia

(2008) M. Arfan Ikram et al.   NEUROBIOLOGY OF AGING

Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

(2008) Oskar Hansson et al.   NEUROBIOLOGY OF AGING

Prevalence and risk factors of cerebral microbleeds: The Rotterdam Scan Study

(2008) M. W. Vernooij et al.   NEUROLOGY

Peripheral A  subspecies as risk biomarkers of Alzheimer's disease

(2008) N. Schupf et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA